Detalles de la búsqueda
1.
Bosutinib-induced late-onset severe liver injury preceded by eosinophilia.
Ann Hematol
; 101(10): 2257-2262, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36002756
2.
[Microgranular-type acute promyelocytic leukemia with weak myeloperoxidase staining: difficulty of morphological diagnosis].
Rinsho Ketsueki
; 61(10): 1511-1513, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-33162450
3.
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.
Ann Hematol
; 97(11): 2081-2088, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29946911
4.
[Chronic myeloid leukemia complicated by pulmonary hypertension during dasatinib therapy: a single-center retrospective study].
Rinsho Ketsueki
; 58(11): 2213-2218, 2017.
Artículo
en Japonés
| MEDLINE | ID: mdl-29212971
5.
[Primary pulmonary Hodgkin lymphoma diagnosed by CT-guided percutaneous biopsy].
Rinsho Ketsueki
; 56(1): 41-3, 2015 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-25745968
6.
Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis.
Hematol Oncol
; 37(3): 323-325, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30950076
7.
Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.
Ann Med
; 54(1): 1244-1254, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486442
8.
The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.
Cancer Med
; 9(23): 8931-8939, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33037866
9.
Potential role for secondgeneration tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.
Oncol Rep
; 42(6): 2836-2843, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578586
10.
Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score.
Leuk Lymphoma
; 59(5): 1105-1112, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838287
11.
Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase.
Med Oncol
; 35(3): 38, 2018 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29442179
12.
Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis.
Med Oncol
; 35(11): 142, 2018 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194496
13.
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors.
Med Oncol
; 35(7): 99, 2018 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846829
14.
Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group.
Leuk Res
; 54: 55-58, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28109974
Resultados
1 -
14
de 14
1
Próxima >
>>